|
Real-time
Oslo Bors
15:18:03 27/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 13.40 NOK | 0.00% |
|
+4.28% | -43.70% |
| 10-20 | Navamedic Extends Nordic Rights for Mysimba Obesity Drug | MT |
| 10-20 | Navamedic ASA Extends Mysimba Distribution Agreement With Azurity Pharmaceuticals | CI |
Chart: Technical Analysis
Oslo BorsNOK
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| NAVA | Real-time | |
CBOE
| NAVAo | Real-time | |
|
CBOE
| 0FDB | Real-time | |
|
Deutsche Boerse AG
| N1A | Delayed | |
|
Börse Stuttgart
| N1A | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 13.75 | 15.7 | 18.75 |
| Spread/Res. | -2.55% | -14.65% | -28.53% |
| Spread/Supp. | +6.35% | +6.35% | +1.13% |
| Support | 12.6 | 12.6 | 13.25 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NAVA Stock
- Charts Navamedic ASA
Select your edition
All financial news and data tailored to specific country editions
